Model, rat
Zucker diabetic fatty in published research
We counted the PubMed papers that name Zucker diabetic fatty in the title or abstract, for every year since 2001. A paper usually gives its strain in the Methods, which PubMed does not hold, so a paper that names it only there is not counted.
- Species
- Rat
- Type
- Model
- Search terms
- One search, under How it was counted
Updated November 12, 2026, from PubMed records through November 8, 2026.
224 papers from 2021 to 2025 name Zucker diabetic fatty rats in the title or abstract
38% fewer than in 2011 to 2015, when 361 papers named it
10th most named of the 27 rat strains, stocks and models, not counting substrains
Papers by year
Papers that name Zucker diabetic fatty rats in the title or abstract, by year. For comparison, 10% fewer papers mentioned rats in 2021 to 2025 than in 2011 to 2015. 2026 is a part year, still filling in.
Papers that name Zucker diabetic fatty rats, by year
- Named in the title or abstract
- Dashed: 2026 so far
Every year's papers
| Year | Named in the title or abstract |
|---|---|
| 2001 | 23 |
| 2002 | 19 |
| 2003 | 20 |
| 2004 | 38 |
| 2005 | 59 |
| 2006 | 41 |
| 2007 | 45 |
| 2008 | 54 |
| 2009 | 61 |
| 2010 | 52 |
| 2011 | 70 |
| 2012 | 71 |
| 2013 | 79 |
| 2014 | 75 |
| 2015 | 66 |
| 2016 | 69 |
| 2017 | 67 |
| 2018 | 50 |
| 2019 | 45 |
| 2020 | 49 |
| 2021 | 53 |
| 2022 | 59 |
| 2023 | 43 |
| 2024 | 36 |
| 2025 | 33 |
| 2026 (part year) | 24 |
Research areas
The research areas its papers from 2021 to 2025 most often fall in, as PubTator 3 labels them, with each area's share of its 224 papers. A paper can fall in several, and an area with fewer than 5 of them is left out. The 25 areas counted cover brain and behavior conditions, pain, diabetes and obesity; cancer, infection and immune disease are not among them.
Named in the same papers
The strains, stocks, models and kinds of line most often named in the same papers from 2021 to 2025, each in at least 5 of them.
Sex of the animals
NLM's indexers tag a paper Male, Female or both for the sex of the animals or people it studies. These are the shares of its tagged papers from 2001 to 2021, in four periods. Of its 1,013 indexed papers from those years, 230 (23%) carry neither tag. Since April 2022 NLM's software sets the tags, so the shares stop at 2021.
- Male only
- Both sexes
- Female only
2001 to 2005111 tagged papers
Male only 87%Both sexes 7%Female only 5%
2006 to 2010191 tagged papers
Male only 79%Both sexes 14%Female only 8%
2011 to 2015266 tagged papers
Male only 88%Both sexes 9%Female only 3%
2016 to 2021215 tagged papers
Male only 89%Both sexes 8%Female only 3%
Most cited papers
The papers naming Zucker diabetic fatty rats with the most citations in iCite, NIH's citation data, as of November 5, 2026, with their titles as published.
All years
- “Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart.”
FASEB J, 2004. Cited 629 times.
- “Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity.”
Endocrinology, 2002. Cited 569 times.
- “Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.”
Sci Transl Med, 2013. Cited 552 times.
- “Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.”
Diabetes Obes Metab, 2012. Cited 504 times.
- “Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.”
JACC Heart Fail, 2016. Cited 493 times.
From 2021 to 2025
- “Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation.”
Cardiovasc Res, 2021. Cited 279 times.
- “Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway.”
Front Pharmacol, 2021. Cited 112 times.
- “GLP-1 alleviates NLRP3 inflammasome-dependent inflammation in perivascular adipose tissue by inhibiting the NF-κB signalling pathway.”
J Int Med Res, 2021. Cited 55 times.
- “Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.”
Front Endocrinol (Lausanne), 2021. Cited 50 times.
- “Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing.”
Bioact Mater, 2022. Cited 49 times.
How it was counted
A paper counts when its PubMed title or abstract matches one of the search terms below, even in passing, as in a review. A match counts only when PubTator 3, NCBI's text-mining service, also finds rats in the same title or abstract. 42 PubMed records matched the terms without that, so they are not counted.
The search terms
Each line is one search, written as a regular expression on the lower-case title and abstract. {mice} stands for mice or mouse, {rats} for rat or rats, {zf} and {zfs} for zebrafish and words such as line, strain or larvae, and {animal} for a word for any lab animal. After && comes a word that must be within 150 characters; after !!, words that rule a match out within 60 characters; and after ~~, words that rule it out anywhere.
zucker diabetic fatty|zdf(?: ?/ ?[a-z]+)?
What is left out
Errata, retraction notices, expressions of concern and preprints. A count is of papers, never of animals, experiments or labs.
Other models
Rat models with a page of their own, by their papers from 2021 to 2025.
- Zucker222 papers
- Goto-Kakizaki180 papers
- TgF344-AD99 papers
- Royal College of Surgeons (RCS)67 papers
- OLETF61 papers
- GAERS58 papers
- Alcohol-preferring (P)46 papers
- Flinders Sensitive Line33 papers
Sources
Every source the counts read, with the terms under which it allows reuse. The counts by year, research area, test and sex are in the downloads.
- PubMed
Titles, abstracts, years, publication types and subject headings (MeSH 2026), from the yearly and daily files
Reuse terms: Courtesy of the U.S. National Library of Medicine. NLM has not endorsed these pages or ConductColony.
- PubTator 3
The species and diseases it finds in each title and abstract
Reuse terms: A U.S. Government work, free to use
- iCite
Citation counts and each strain's most-cited papers, in the full data file
Reuse terms: CC BY 4.0, from the NIH Office of Portfolio Analysis
- MGI,RGDandZFIN
Official strain names and identifiers for mice (MGI), rats (RGD) and zebrafish (ZFIN), in the strain list
Reuse terms: CC BY 4.0, from The Jackson Laboratory, the Medical College of Wisconsin and the University of Oregon
| Source | What the pages take | Reuse terms |
|---|---|---|
| PubMed | Titles, abstracts, years, publication types and subject headings (MeSH 2026), from the yearly and daily files | Courtesy of the U.S. National Library of Medicine. NLM has not endorsed these pages or ConductColony. |
| PubTator 3 | The species and diseases it finds in each title and abstract | A U.S. Government work, free to use |
| iCite | Citation counts and each strain's most-cited papers, in the full data file | CC BY 4.0, from the NIH Office of Portfolio Analysis |
| MGI,RGDandZFIN | Official strain names and identifiers for mice (MGI), rats (RGD) and zebrafish (ZFIN), in the strain list | CC BY 4.0, from The Jackson Laboratory, the Medical College of Wisconsin and the University of Oregon |
How to cite
APA
ConductScience. (2026, November 12). Zucker diabetic fatty in published research [Data set]. https://conductcolony.com/
BibTeX
@misc{conductscience_zdf_2026,
author = {{ConductScience}},
title = {Zucker diabetic fatty in published research},
year = {2026},
month = nov,
url = {https://conductcolony.com/data/strains/zdf},
note = {Data set, released November 12, 2026},
}Dates
- Data built
- November 12, 2026
- PubMed records through
- November 8, 2026
- PubTator 3 file of
- October 6, 2026
- iCite file of
- November 5, 2026
- MGI, RGD and ZFIN strain files read
- November 12, 2026